Evaluation of the Safety of Deutetrabenazine at Higher Doses to Treat Chorea in Huntington's Disease

被引:0
|
作者
Frank, S. [1 ]
Vaughan, C. [1 ]
Stamler, D. [1 ]
Oakes, D. [1 ]
Davis, M. [1 ]
Gross, N. [1 ]
Gordon, M. [1 ]
Savola, J. M. [1 ]
Wieman, M. [1 ]
Eberly, S. [1 ]
Kayson, E. [1 ]
Whaley, J. [1 ]
Goldstein, J. [1 ]
Testa, C. [1 ]
机构
[1] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
246
引用
收藏
页码:S98 / S98
页数:1
相关论文
共 50 条
  • [21] Clinical Utility of Deutetrabenazine as a Treatment Option for Chorea Associated with Huntington's Disease and Tardive Dyskinesia
    Frank, Samuel
    Alakkas, Aljoharah
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2023, 19 : 1019 - 1024
  • [22] Deutetrabenazine in the treatment of Huntington's disease
    Richard, Alby
    Frank, Samuel
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2019, 9 (01) : 31 - 36
  • [23] Deutetrabenazine for tardive dyskinesia and chorea associated with Huntington?s disease: a review of clinical trial data
    Claassen, Daniel O.
    Philbin, Michael
    Carroll, Benjamin
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (18) : 2209 - 2221
  • [24] A new drug to treat chorea in Huntington disease
    Wood, Heather
    NATURE REVIEWS NEUROLOGY, 2023, 19 (07) : 387 - 387
  • [25] Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease A Randomized Clinical Trial
    Frank, Samuel
    Testa, Claudia M.
    Stamler, David
    Kayson, Elise
    Davis, Charles
    Edmondson, Mary C.
    Kinel, Shari
    Leavitt, Blair
    Oakes, David
    O'Neill, Christine
    Vaughan, Christina
    Goldstein, Jody
    Herzog, Margaret
    Snively, Victoria
    Whaley, Jacquelyn
    Wong, Cynthia
    Suter, Greg
    Jankovic, Joseph
    Jimenez-Shahed, Joohi
    Hunter, Christine
    Claassen, Daniel O.
    Roman, Olivia C.
    Sung, Victor
    Smith, Jenna
    Janicki, Sarah
    Clouse, Ronda
    Saint-Hilaire, Marie
    Hohler, Anna
    Turpin, Denyse
    James, Raymond C.
    Rodriguez, Ramon
    Rizer, Kyle
    Anderson, Karen E.
    Heller, Hope
    Carlson, Alexis
    Criswell, Susan
    Racette, Brad A.
    Revilla, Fredy J.
    Nucifora, Frederick, Jr.
    Margolis, Russell L.
    Ong, MaryJane
    Mendis, Tilak
    Mendis, Neila
    Singer, Carlos
    Quesada, Monica
    Paulsen, Jane S.
    Brashers-Krug, Thomas
    Miller, Amanda
    Kerr, Jane
    Dubinsky, Richard M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (01): : 40 - 50
  • [26] A new drug to treat chorea in Huntington disease
    Heather Wood
    Nature Reviews Neurology, 2023, 19 : 387 - 387
  • [27] Incidence of Adverse Events Associated With Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated With Huntington's Disease
    Anderson, Karen E.
    Fernandez, Hubert H.
    Frank, Samuel
    Factor, Stewart A.
    Hauser, Robert A.
    Jimenez-Shahed, Joohi
    Barkay, Hadas
    Wilhelm, Amanda
    Alexander, Jessica
    Chaijale, Nayla
    Send, Alexander F.
    Savola, Juha-Matti
    Stamler, David
    Gordon, Mark Forrest
    Chen, Maria
    NEUROLOGY, 2021, 96 (15)
  • [28] Long-term Deutetrabenazine Safety on Motor, Psychiatric, and Cognitive Measures in Individuals With Chorea Associated With Huntington Disease
    Gordon, M.
    Stamler, D.
    Savola, J.
    Gross, N.
    Barkay, H.
    Chen, M.
    Chaijale, N.
    MOVEMENT DISORDERS, 2022, 37 : S298 - S299
  • [29] Real-World Effectiveness and Safety of Deutetrabenazine in Combination with Antipsychotic Drugs in Patients With Chorea Associated With Huntington Disease
    Claassen, Daniel
    Romdhani, Hela
    Ayyagari, Rajeev
    Goldschmidt, Debbie
    Moroz, Sarah
    Hernandez, Adreanna
    Chaijale, Nayla
    Leo, Sam
    NEUROLOGY, 2023, 100 (17)
  • [30] Profiling deutetrabenazine extended-release tablets for tardive dyskinesia and chorea associated with Huntington's disease
    Moondra, P.
    Jimenez-Shahed, J.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2024, 24 (09) : 849 - 863